GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said. (Credit: Jason Alden/Bloomberg via Getty Images)

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases.

During her eight years at the helm of the pharmaceutical group, Walmsley is starting to get the hang of how to effectively recruit and retain that talent, and when to cut loose.